(VIANEWS) – Pfizer (PFE), j2 Global (JCOM), DENTSPLY SIRONA (XRAY) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Pfizer (PFE)

62.5% sales growth and 14.03% return on equity

Pfizer Inc. develops, manufactures, and sells healthcare products worldwide.

Pfizer’s sales growth this year is expected to be 74.9% and a negative 15% for next year.

Year-on-year quarterly revenue growth grew by 44.6%, now sitting on 46.41B for the twelve trailing months.

Volume

Today’s last reported volume for Pfizer is 7378180 which is 70.81% below its average volume of 25278600.

Pfizer’s sales growth for the next quarter is 62.5%. The company’s growth estimates for the present quarter and the next is 25.6% and 44.4%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.03%.

Volatility

Pfizer’s last day, last week, and last month’s current volatility was 0.07%, 0.76%, and 0.59%, respectively.

Pfizer’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.78% (day), 1.82% (last week), and 1.31% (last month), respectively.

Pfizer’s Stock Yearly Top and Bottom Value

Pfizer’s stock is valued at $41.24 at 12:22 EST, below its 52-week high of $43.08 and way above its 52-week low of $32.83.

Pfizer’s Moving Average

Pfizer’s worth is higher than its 50-day moving average of $39.56 and higher than its 200-day moving average of $37.50.

Previous days news about Pfizer(PFE)

According to Market Watch on Monday, 19 July, "BioNTech has become a well-known name outside of biotech circles since developing a COVID-19 vaccine with Pfizer Inc. . "

Pfizer vaccine partner biontech inks cancer deal. According to The Wall Street Journal on Monday, 19 July, "BioNTech shot to fame for the Covid-19 vaccine that it co-developed with Pfizer Inc. –the first shot authorized for use in the U.S. and Europe. "

According to MarketWatch on Monday, 19 July, "Read also: Pfizer says FDA’s decision to approve its COVID-19 vaccine is expected by January"

According to Bloomberg Quint on Monday, 19 July, "About five million have been vaccinated in the U.S. to date, and trials are ongoing for the Pfizer shot in younger children, with data expected later this year.", "While the European Union authorized the use of the Pfizer vaccine in children aged 12 and over in May and the U.K. in June, much of Europe has moved slowly on rolling it out to kids."

2. j2 Global (JCOM)

22.4% sales growth and 18.68% return on equity

J2 Global, Inc., together with its subsidiaries, provides Internet services worldwide.

j2 Global’s sales growth this year is expected to be 14% and 7.1% for next year.

Year-on-year quarterly revenue growth grew by 19.8%, now sitting on 1.56B for the twelve trailing months.

Volume

Today’s last reported volume for j2 Global is 154511 which is 72.68% below its average volume of 565557.

j2 Global’s sales growth for the next quarter is 22.4%. The company’s growth estimates for the ongoing quarter and the next is 18.7% and 7.4%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.68%.

Volatility

j2 Global’s last day, last week, and last month’s current volatility was 0.04%, 0.38%, and 1.41%, respectively.

j2 Global’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.81% (day), 2.38% (last week), and 2.89% (last month), respectively.

j2 Global’s Stock Yearly Top and Bottom Value

j2 Global’s stock is valued at $142.59 at 12:22 EST, under its 52-week high of $145.55 and way higher than its 52-week low of $53.25.

j2 Global’s Moving Average

j2 Global’s value is higher than its 50-day moving average of $135.15 and way above its 200-day moving average of $119.61.

3. DENTSPLY SIRONA (XRAY)

22% sales growth and 3.62% return on equity

DENTSPLY SIRONA Inc. designs, develops, manufactures, distributes, and sells various dental products and technologies primarily for professional dental market worldwide.

DENTSPLY SIRONA’s sales growth this year is anticipated to be 27.1% and 5.2% for next year.

Year-on-year quarterly revenue growth grew by 17.5%, now sitting on 3.5B for the twelve trailing months.

Volume

Today’s last reported volume for DENTSPLY SIRONA is 1219110 which is 14.3% below its average volume of 1422520.

DENTSPLY SIRONA’s sales growth for the next quarter is 22%. The company’s growth estimates for the current quarter and the next is 461.1% and negative -1.5%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.62%.

Volatility

DENTSPLY SIRONA’s last day, last week, and last month’s current volatility was 0.66%, 0.53%, and 1.20%, respectively.

DENTSPLY SIRONA’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.29% (day), 1.44% (last week), and 2.16% (last month), respectively.

DENTSPLY SIRONA’s Stock Yearly Top and Bottom Value

DENTSPLY SIRONA’s stock is valued at $63.76 at 12:22 EST, below its 52-week high of $69.54 and way higher than its 52-week low of $41.52.

DENTSPLY SIRONA’s Moving Average

DENTSPLY SIRONA’s worth is under its 50-day moving average of $63.96 and higher than its 200-day moving average of $62.04.

4. CRA International (CRAI)

13.1% sales growth and 14% return on equity

CRA International, Inc., a consulting company, provides economic, financial, and management consulting services in the United States, the United Kingdom, and internationally.

CRA International’s sales growth this year is expected to be 10.4% and 5.9% for next year.

Year-on-year quarterly revenue growth grew by 16.1%, now sitting on 528.73M for the twelve trailing months.

Volume

Today’s last reported volume for CRA International is 36867 which is 11.56% below its average volume of 41687.

CRA International’s sales growth for the next quarter is 13.1%. The company’s growth estimates for the present quarter and the next is 16.2% and 23.7%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14%.

Volatility

CRA International’s last day, last week, and last month’s current volatility was 0.81%, 0.96%, and 1.13%, respectively.

CRA International’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.00% (day), 3.05% (last week), and 3.61% (last month), respectively.

CRA International’s Stock Yearly Top and Bottom Value

CRA International’s stock is valued at $83.56 at 12:22 EST, below its 52-week high of $90.59 and way above its 52-week low of $36.32.

CRA International’s Moving Average

CRA International’s value is below its 50-day moving average of $84.83 and way above its 200-day moving average of $72.30.

5. Lincoln Educational Services Corporation (LINC)

7.1% sales growth and 68.62% return on equity

Lincoln Educational Services Corporation, together with its subsidiaries, provides various career-oriented post-secondary education services to high school graduates and working adults in the United States.

Lincoln Educational Services Corporation’s sales growth this year is anticipated to be 10.8% and 7.5% for next year.

Year-on-year quarterly revenue growth grew by 11.4%, now sitting on 301.05M for the twelve trailing months.

Volume

Today’s last reported volume for Lincoln Educational Services Corporation is 53051 which is 60.94% below its average volume of 135836.

Lincoln Educational Services Corporation’s sales growth for the next quarter is 7.1%. The company’s growth estimates for the present quarter and the next is 50% and 50%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 68.62%.

Volatility

Lincoln Educational Services Corporation’s last day, last week, and last month’s current volatility was 1.97%, 0.84%, and 1.47%, respectively.

Lincoln Educational Services Corporation’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.11% (day), 2.79% (last week), and 4.09% (last month), respectively.

Lincoln Educational Services Corporation’s Stock Yearly Top and Bottom Value

Lincoln Educational Services Corporation’s stock is valued at $7.04 at 12:22 EST, way under its 52-week high of $8.99 and way higher than its 52-week low of $4.42.

Lincoln Educational Services Corporation’s Moving Average

Lincoln Educational Services Corporation’s worth is under its 50-day moving average of $7.55 and higher than its 200-day moving average of $6.75.

6. Brightcove (BCOV)

7% sales growth and 9.17% return on equity

Brightcove Inc. provides cloud-based services for video.

Brightcove’s sales growth this year is anticipated to be 8.9% and 10.6% for next year.

Year-on-year quarterly revenue growth grew by 17.5%, now sitting on 205.52M for the twelve trailing months.

Volume

Today’s last reported volume for Brightcove is 97502 which is 71.52% below its average volume of 342361.

Brightcove’s sales growth for the next quarter is 7%. The company’s growth estimates for the present quarter and the next is a negative 57.1% and 18.2%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.17%.

Volatility

Brightcove’s last day, last week, and last month’s current volatility was 2.00%, 1.71%, and 2.18%, respectively.

Brightcove’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.33% (day), 3.19% (last week), and 4.12% (last month), respectively.

Brightcove’s Stock Yearly Top and Bottom Value

Brightcove’s stock is valued at $12.90 at 12:22 EST, way under its 52-week high of $25.26 and way above its 52-week low of $7.83.

Brightcove’s Moving Average

Brightcove’s value is below its 50-day moving average of $13.89 and way under its 200-day moving average of $17.64.

LEAVE A REPLY

Please enter your comment!
Please enter your name here